Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	6.35B +28.7%
Revenue (ttm)	2.91B +7.1%
Net Income	146.79M +2.1%
EPS	3.98 -21.1%
Shares Out	38.83M
PE Ratio	41.11
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,056
Open	165.25
Previous Close	164.88
Day's Range	155.00 - 168.57
52-Week Range	92.00 - 209.95
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 5, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 460
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.88 billion, an increase of 4.78% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 23, 2026

Data Sources Report a data error